| Code | 9487E | ||||||||||
| MA number | EU/1/24/1826/001 | ||||||||||
| Product Form: | con inf 3x0,1 ml/10 µg (striek.inj.napl.skl.+5 kanýl) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Lindis Biotech GmbH, Germany | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Intraperitoneal use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 10.02.2025 |
| Validity: | 10.02.2030 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | Yes |
| Data update: | 03.04.2025 |
